Effect of a rituximab-based regimen on the incidence of CNS relapse in patients with diffuse large B-cell lymphoma.

被引：0
|
作者：
Mahrous, M.
Buckstein, R.
Piliotis, E.
Cheung, M. C.
Berinstein, N. L.
机构：
[1] Minia Oncol Ctr, El Mina, Egypt
[2] Odette Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.8098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8098
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome
    Vannata, Barbara
    Conconi, Annarita
    Winkler, Jonas
    Cascione, Luciano
    Casaluci, Gloria Margiotta
    Nassi, Luca
    Moia, Riccardo
    Pirosa, Maria Cristina
    Moccia, Alden A.
    Stathis, Anastasios
    Rossi, Davide
    Gaidano, Gianluca
    Zucca, Emanuele
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (04) : 478 - 487
  • [2] Prevention of CNS relapse in diffuse large B-cell lymphoma
    Kridel, Robert
    Dietrich, Pierre-Yves
    [J]. LANCET ONCOLOGY, 2011, 12 (13): : 1258 - 1266
  • [3] Improved Survival with Rituximab-Based Chemoimmunotherapy in Patients with Primary Testicular Diffuse Large B-Cell Lymphoma
    He, Shengli
    Chen, Menghao
    Miao, Yi
    [J]. BLOOD, 2023, 142
  • [4] Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
    Olszewski, Adam J.
    Winer, Eric S.
    Castillo, Jorge J.
    [J]. LEUKEMIA RESEARCH, 2014, 38 (08) : 866 - 873
  • [5] RITUXIMAB-BASED REGIMEN AS FRONTLINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD NATIONWIDE COHORT STUDY
    Ko, B. S.
    Huang, H. H.
    Wang, C. Y.
    Chen, H. M.
    Hsiao, F. Y. S.
    [J]. VALUE IN HEALTH, 2019, 22 : S435 - S435
  • [6] Diffuse Large B-Cell Lymphoma with Testicular Involvement: Outcome and Risk of CNS Relapse in the Rituximab Era
    Telio, David
    Villa, Diego
    Shenkier, Tamara
    Sehn, Laurie H.
    Klasa, Richard
    Tan, King
    Gascoyne, Randy D.
    Connors, Joseph M.
    Savage, Kerry J.
    [J]. BLOOD, 2011, 118 (21) : 354 - 354
  • [7] Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era
    Kridel, Robert
    Telio, David
    Villa, Diego
    Sehn, Laurie H.
    Gerrie, Alina S.
    Shenkier, Tamara
    Klasa, Richard
    Slack, Graham W.
    Tan, King
    Gascoyne, Randy D.
    Connors, Joseph M.
    Savage, Kerry J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (02) : 210 - 221
  • [8] Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma
    Olszewski, Adam J.
    Mantripragada, Kalyan C.
    Castillo, Jorge J.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (09): : 1121 - 1129
  • [9] Cost-effectiveness of rituximab in treatment of diffuse large B-cell lymphoma.
    Coiffier, B
    Best, JH
    Omnes, LF
    Hornberger, JC
    [J]. BLOOD, 2001, 98 (11) : 864A - 864A
  • [10] THE IMPACT OF ADDITION OF RITUXIMAB TO CHEMOTHERAPY ON INCIDENCE OF CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Law, M.
    Yip, S.
    Chan, H.
    Lai, H.
    Ha, C.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 226 - 226
12345